Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
02/06/2026 13:15
BRIEF-U.S. District Court Issues Decision Regarding CINVANTI Patents June 2 (Reuters) - Heron Therapeutics Inc HRTX.O:
U.S. DISTRICT COURT ISSUES DECISION REGARDING CINVANTI® PATENTS
HERON THERAPEUTICS - U.S. COURT RULES ASSERTED CLAIMS OF HERON'S CINVANTI PATENTS INVALID
HERON THERAPEUTICS - DECISION DOES NOT IMPACT PRIOR SETTLEMENTS RELATED TO CINVANTI OR APONVIE
HERON THERAPEUTICS - TO APPEAL PATENT DECISION TO FEDERAL CIRCUIT COURT
Source text: ID:nGNX8mY79x
Further company coverage: HRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heron Therapeutics
See all newsHeron Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Heron Therapeutics Q2 revenue rises on acute care growth, withdraws 2026 outlook
Heron Therapeutics Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: U.S. District Court Issues Decision Regarding CINVANTI Patents
Heron Therapeutics' Q1 revenue falls as oncology sales drop